Capital De Empréstimo Alterar Data
Acadia Pharmaceuticals USD 0 0 2025-03
Amgen USD 51.89B 1.88B 2026-03
Bayer EUR 30.68B 1.15B 2026-03
Biogen USD 6.29B 1.7M 2026-03
Brainstorm Cell Therapeutics USD 0 0 2025-03
Bristol-Myers Squibb USD 42.15B 698M 2026-03
Capricor Therapeutics USD 3.38M 0 2025-03
Cytokinetics USD 247.21M 868.77M 2026-03
Eisai JPY 134.78B 12M 2026-03
Eli Lilly USD 39.37B 1.5B 2026-03
Geron USD 119.83M 286K 2026-03
Halozyme Therapeutics USD 1.94B 206.73M 2026-03
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
Ligand Pharmaceuticals USD 446.19M 702K 2025-12
Merck USD 46.67B 77M 2026-03
Novartis USD 37.45B 7.86B 2026-03
Pfizer USD 60.57B 1.08B 2026-03
Regeneron Pharmaceuticals USD 1.99B 719.7M 2026-03
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 13.84B 1.88B 2026-03